merged_ftc-pharmacy-benefit-managers-drug-prices.txt


<question_number>1</question_number>
<answer>N/A</answer>
<other>The FTC has not yet brought a lawsuit against PBMs according to the text.</other>

<question_number>2</question_number>
<answer>N/A</answer>
<other>The article mentions integration by 2018 but doesn't specify Caremark's acquisition year.</other>

<question_number>3</question_number>
<answer>N/A</answer>
<other>The $1.6 billion figure refers to PBM revenue, not direct patient overpayment estimates.</other>